Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

75.40p
   
  • Change Today:
      0.30p
  • 52 Week High: 87.50
  • 52 Week Low: 57.20
  • Currency: UK Pounds
  • Shares Issued: 531.00m
  • Volume: 429,041
  • Market Cap: £400.37m
  • RiskGrade: 207

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 75.40p per share. In the last year Alliance Pharma's share price has ranged from 57.20p to 87.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart (02-06-2020)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.7% 2.2%
Div Cover 9.5 2.9
Op Mrgn 26.3% 22.8%
ROCE 68.0%  
Latest F'cast
P/E 14.8 15.4
PEG 1.2 n/a
Pr/Revenue 3.0 2.9
Pr/Book 1.5  
Latest F'cast
Revenue 14.7% 3.0%
PBT 36.3% 2.6%
EPS 12.1% -4.0%
DPS -63.4% 210.4%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 139.67 31.89 4.89p 15.4 n/a -4% 1.66p 2.2%
31-Dec-21 148.00 35.61 5.46p 13.8 1.2 +12% 1.84p 2.4%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Notification of Major Holdings 02-Jun-2020 15:33 RNS
Total Voting Rights 01-Jun-2020 11:06 RNS
Notification of Major Holdings 29-May-2020 17:21 RNS

Alliance Pharma ShareCast News

Alliance Pharma lowers net debt after "strong" r... 22-Jan-2020 ShareCast
Alliance Pharma handing back 'Xonvea' rights to ... 27-Nov-2019 ShareCast
Alliance Pharma revenues increase as product por... 17-Jul-2019 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

Traded Action Notifier PriceAmountValue
07-May-20 Sell Peter Butterfield 7,470.00p 161,915 £12,095,050.01
07-May-20 Exercise of option Peter Butterfield 4,750.00p 200,000 £9,500,000.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 75.40p
Change Today 0.30p
% Change 0.40 %
52 Week High 87.50
52 Week Low 57.20
Volume 429,041
Shares Issued 531.00m
Market Cap £400.37m
RiskGrade 207

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.15% below the market average62.15% below the market average62.15% below the market average62.15% below the market average62.15% below the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average
Price Trend
26.50% above the market average26.50% above the market average26.50% above the market average26.50% above the market average26.50% above the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average
Income
39.76% below the market average39.76% below the market average39.76% below the market average39.76% below the market average39.76% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Growth
36.92% above the market average36.92% above the market average36.92% above the market average36.92% above the market average36.92% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Dec-19 13-Jun-19
Paid 10-Jan-20 11-Jul-19
Amount 0.54p 0.98p

Trades for 02-Jun-2020

Time Volume / Share Price
16:38 100,000 @ 75.17p
16:35 20,135 @ 75.40p
16:29 218 @ 75.90p
16:29 641 @ 75.90p
16:29 487 @ 75.90p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page